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Abstract
Pulmonary alveolar proteinosis is a very rare interstitial lung disease caused by abnormal intra-alveolar surfactant accumulation. 
Usually, it appears as a „crazy-paving” pattern on high-resolution computed tomography. The image is so typical, that together 
with the characteristic bronchoalveolar lavage examination with presence of Periodic Acid Schiff positive substance is sufficient 
for establishing diagnosis, without histological confirmation. We present the case of the young woman with severe dyspnoea 
suspected of acute hypersensitivity pneumonia. The computed tomography showed numerous intralobular nodules uniformly 
distributed troughout the lungs. Treatment by corticosteroids had no clinical effect and next computed tomography showed 
progression. Despite the high risk of complications (patient had a respiratory failure), a surgical lung biopsy was performed and 
the histopathological diagnosis of pulmonary alveolar proteinosis was made. The whole lung lavage procedure performed twice 
caused regression of radiological lesions and respiratory failure. 
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Introduction
Pulmonary alveolar proteinosis (PAP) is a rare 
disease with a prevalence of 3.7–6.2/1 000 000. 
There are three main forms of PAP: hereditary, 
secondary and autoimmune, but common to all 
is impaired clearance of surfactant by alveolar 
macrophages, resulting its retention in the termi-
nal airway and in the alveolar space [1]. A chest 
computed tomography (CT) commonly showing 
a „crazy-paving” pattern, is a major tool in the 
diagnosis of PAP. The image is so typical, that to-
gether with the characteristic bronchoalveolar la-
vage (BAL) examination with presence of Periodic 
Acid Schiff (PAS) positive substance is sufficient 
for establishing diagnosis [2]. We present the case 
of the young woman with severe dyspnoea and 
radiological image suggesting hypersensitivity 
pneumonia (HP). The final diagnosis of PAP was 
established basing on the histological examina-
tion of surgical lung biopsy specimens. 
Case report
A 31-year-old caucasian woman admitted to 
National Research Institute of Tuberculosis and 
Lung Diseases with a 1 month history of worse-
ning dyspnoea and cough, without fever. She was 
non-smoker and reported exposure to chemical 
compounds — last 6 months she worked on the 
production of car mats (exposure to lead, zinc, 
solvents) and she had a contact with the pigeons, 
but it was an accidental exposure. Before her 
admission she had been treated by empirical anti-
biotics and bronchodilators without improvement. 
On admission she was in severe general 
condition. Respiratory rate was 28 breaths per 
min, heart rate 120 beats per min, and oxygen 
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saturation was 68% on room air. Chest exami-
nation showed good air entry with no abnormal 
sounds. Her full blood count, C-reactive protein, 
antinuclear antibodies and complement levels 
were normal, but she had a raised lactate dehydro-
genase (LDH) concentration of 1123 U/L (normal 
200–384 U/L). Pulmonary function tests showed 
reduced diffusing capacity of the lung for carbon 
monoxide (DLCO) to a severe degree (35% N). 
Chest radiograph showed bilateral non-specific 
disseminated lesions and high resolution com-
puted tomography (HRCT) appeared numerous 
intralobular nodules uniformly distributed thro-
ughout the lungs (Figure 1). Based on the HRCT 
image together with the exposure to the pigeons’ 
antigens in medical history, HP was strongly 
suspected. Patient received 30 mg of prednisone 
without clinical improvement and respiratory 
failure remained (Pa02 = 32–40 mm Hg). She 
required oxygen supplementation 3–5 L/min, 
despite increased dose of corticosteroids (CS) to 
60 mg daily. Control HRCT showed a progression 
of the intralobular opacities with the appearance 
of the discrete „septal thickening”. Bronchosco-
py with transbronchial lung biopsy (TBLB) was 
performed, but histological examination was 
not conclusive. All cultures were negative. Pa-
tient underwent bronchoalveolar lavage, but the 
procedure had to be stopped, because of severe 
dyspnoea with decrease of the oxygen saturation. 
After 3 weeks of corticotherapy without marked 
improvement, surgical lung biopsy was performed 
to determine the diagnosis. The histopathological 
examination revealed alveoli and terminal bron-
chioles filled with an eosinophilic proteinaceous 
material that stained pink with PAS — the diagno-
sis was PAP (Figure 2). Anti-granulocyte macro-
phage — colony stimulating factor (anti-GM-CSF) 
antibody concentrations — the gold standard for 
diagnosis of autoimmune PAP — is not available 
in Poland. The CS were gradually eliminated and 
stopped and whole lung lavage (WLL) with 10 L 
of 0.9% saline was performed (in the operating 
room under general anaesthesia). Directly after 
one procedure, the clinical improvement was 
observed. At last follow-up after 6 weeks, the 
patient was asymptomatic and chest radiograph 
showed regression of the disseminated lesions 
(Figure 3A, B).
Discussion
PAP is a rare syndrome characterized by the 
accumulation of surfactant — like substance in 
pulmonary alveoli resulting in varying degrees 
of respiratory insufficiency and myeloid cell 
dysfunction resulting in increased risk of infec-
tion [1]. Autoimmune PAP occurs, when anti — 
GM-CSF antibodies block activation of alveolar 
macrophages. It is the most common type of PAP 
and accounts for 90% cases. Congenital PAP is 
caused by mutations in surfactant proteins ge-
nes B or C, ABCA3 and a chain of the GM-CSF 
receptor. Secondary PAP is an acquired defect 
of malignancies, inhalation of inorganic agents 
or opportunistic infections [3]. Our patient had 
exposure to chemical compound, like lead, zinc 
and solvents during last 6 months, which may 
suggest the secondary type of the disease, but 
recent studies showed, that a history of chemical 
substances inhalation may be strongly associated 
also with the autoimmune form of PAP [4]. A 
Differentiating factor could be examination of the 
Figure 1. High-resolution computed tomography scan showing atypi-
cal image of PAP — numerous diffuse intralobular nodules
Figure 2. Surgical biopsy photomicrograph — alveoli filled with 
PAS-positive staining substance (original × 400)
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Figure 3A. Chest radiograph before whole lung lavage — visible 
disseminated lesions in the lungs
 Figure 3B. Chest radiograph after whole lung lavage — complete 
regression of lesions
Figure 4. High-resolution computed tomography scan showing typical 
image of PAP: ground-glass opacities with visible polygonal structures 
— the so-called „crazy paving” pattern (from own collection of the 
Third Department of Pneumonology, National Research Institute of 
Tuberculosis and Lung Diseases)
anti-GM-CSF antibody concentration in patient’s 
serum, but in Poland it is not available. On the 
other hand, autoantibodies are detected also in 
secondary PAP, but are much less common [5]. 
IgG anti-GM-CSF have been described in a patient 
with PAP secondary to exposure to indium [6]. 
The most often symptoms of PAP are dysp-
noea and cough (39–79%), which are common, 
but non-specific symptoms seen by medical prac-
titioners [3]. An important examination for the 
diagnosis of PAP is HRCT, which shows lesions 
in the form of ground-glass opacities with visi-
ble polygonal structures — the so-called „crazy 
paving” pattern. The areas of filled alveoli are 
usually separated from the normal lung parenchy-
ma making a geographical pattern (Figure 4) [7]. 
Vrielynck et al. evaluated the accuracy of chest 
CT in the differential diagnosis of chronic infiltra-
tive lung disease in children. Among a cohort of 
59 patients with nine disorders, PAP was the most 
frequently properly diagnosed (72%), showing 
that the HRCT appearance of PAP is suggestive 
of the disease [8]. Current guidelines imply, that 
characteristic image of HRCT together with a 
typical results of the examination of BAL are suf-
ficient criteria for establishing diagnosis, without 
histological confirmation [2, 7]. Unfortunately, in 
our patient we have not received material from 
BAL, because of severe respiratory failure. On the 
other hand, HRCT showed multiple intralobular 
nodules uncharacteristic for PAP and in this 
situation typical BAL examination could not be 
sufficient for diagnosis of PAP. Clinical course of 
disease was against of HP diagnosis and surgical 
lung biopsy was necessary. Perhaps, the decision 
to proceed surgical biopsy could be taken at the 
time the lack of therapeutic effect of 30 mg of 
prednisone, but patient was in a serious condition 
with respiratory failure and we wanted to take the 
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opportunity of optimal treatment, before deciding 
on the invasive procedure. Our case shows, that 
HRCT image of PAP can be atypical and uncha-
racteristic, which may hinder correct diagnosis. 
Intralobular nodules observed in our patient con-
form an unusual and occasional manifestation of 
PAP. In the Holbert’s et al study investigating the 
HRCT features of PAP in a group of 27 patients, 
intralobular lesions were found only in two cases 
(7.4%) [9], while Berteloot et al found intralobular 
nodules only in one case of PAP (4.2%) [10]. In the 
material of Fijolek et al., among the 17 patients 
with PAP, in 4 cases another interstitial diseases 
were considered, but PAP was also taken into 
account [11]. Although the nodular appearance 
of PAP on HRCT could not be clearly explained, 
the appearance of such pattern may suggest very 
early PAP in patients. 
There are no firm criteria for initiation of 
therapy of PAP, but according to the majority of 
authors, the treatment is necessary in case of 
hypoxaemia (Pa02 < 65 mm Hg or < 60 mm Hg) 
or saturation below 90%, the growth of alveolo-
capillary gradient of oxygen partial pressure 
above 40 mm Hg, pulmonary shunt exceeding 
10–12% and/or dyspnoea limiting daily activities 
of the patient [12, 13]. Still the most effective and 
safe method of treatment is WLL, which removes 
surfactant-like material from the alveoli [7, 11, 
14]. The improvement starts within days and is 
sustainable in many. Usually, oxygenation impro-
ves first, chest imaging shows varying degrees of 
resolution, but complete resolution of opacities 
is uncommon. Our patient met the eligibility cri-
teria for treatment and improvement was quickly 
observed — few days after WLL blood gases nor-
malized, and follow-up HRCT image performed 
6 weeks later showed almost complete regression 
of the disease. 
In conclusion, radiological image of PAP at 
HRCT is usually typical and it is decisive for dia-
gnosis, but sometimes HRCT is not characteristic 
and may suggest other disease. Bilateral diffuse 
intralobular nodules can be caused by infection, 
panbronchiolitis, vasculitis and vascular meta-
stases, respiratory bronchiolitis-interstitial lung 
disease, HP and pneumoconiosis [15]. Our case 
shows, that in case of disseminated intralobular 
nodules in CT, PAP — although exteremely rare 
— should be taken into consideration in diffe-
rential diagnosis. Our conclusion is, that in cases 
of undiagnosed diffuse pulmonary disease, espe-
cially in young patients the surgical lung biopsy 
should be performed. The precise diagnosis is 
necessary to implement appropriate treatment, 
without exposing the patient to the inadequate 
therapy and its possible side effects. 
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